NYSE issues a pre-market daily advisory direct from the trading floor.

NEW YORK, July 15, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

Global Game Summit kicks off from New Jersey

Kristen Scholer delivers the pre-market update on July 15th

  • Investors parse through June’s Producer Price Index, showing the latest movement in wholesale price inflation.
  • Direxion launches SKHL ETF on NYSE Arca, which provides 2x daily exposure to SK Hynix.
  • FIFA World Cup 2026 NYNJ Host Committee CEO Alex Lasry sets the scene for the upcoming World Cup Final.
    • NYSE Live will provide exclusive coverage of Lasry’s remarks before the Opening Bell.
  • The Global Game Summit, which gathers leaders from across soccer, business, tech, and media ecosystems commences from the Prudential Center in Newark, NJ.
  • Women’s Health Week report shows equity investments in women’s health reached $1.55 billion in 2025.

Opening Bell
FIFA World Cup 2026 New York New Jersey Host Committee rings the Opening Bell

Closing Bell
Abacus Global Management (NYSE: ABX) rings the Closing Bell

For market insights, IPO activity, and today’s opening bell, download the NYSE TV App: TV.NYSE.com

Zeta Global at the NYSE on July 14
Zeta Global at the NYSE on July 14

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044

WUHAN, China, Jan. 3, 2025 /PRNewswire/ — Hanx Biopharmaceuticals, CO. Ltd, an…

Vooglam Unveils New Half-Rim Eyewear Collection: "Never Be Boxed In"

AUSTIN, Texas, June 8, 2024 /PRNewswire/ — Vooglam, a leading fashion eyewear…

Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatment of Colon Cancer at 2024 ASCO Annual Meeting

SAN FRANCISCO and SUZHOU, China, June 3, 2024 /PRNewswire/ — Innovent Biologics,…